Oral Brexanolone Phase 3 Failure: Why Ketamine Remains the Rapid-Acting Standard - The Clinical Trial Vanguard

Submitted by Anonymous (not verified) on Tue, 04/07/2026 - 11:40

Oral Brexanolone Phase 3 Failure: Why Ketamine Remains the Rapid-Acting Standard  The Clinical Trial Vanguard